Reported Earnings • Jul 31
Second quarter 2026 earnings released: EPS: Rp5.74 (vs Rp14.22 in 2Q 2025) Second quarter 2026 results: EPS: Rp5.74 (down from Rp14.22 in 2Q 2025). Revenue: Rp87.6b (down 1.7% from 2Q 2025). Net income: Rp2.00b (down 60% from 2Q 2025). Profit margin: 2.3% (down from 5.6% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Jun 14
PT Asuransi Bintang Tbk announces Annual dividend, payable on July 02, 2026 PT Asuransi Bintang Tbk announced Annual dividend of IDR 5.7000 per share payable on July 02, 2026, ex-date on June 22, 2026 and record date on June 23, 2026. Announcement • May 05
PT Asuransi Bintang Tbk, Annual General Meeting, Jun 10, 2026 PT Asuransi Bintang Tbk, Annual General Meeting, Jun 10, 2026. New Risk • Apr 05
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 314% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (Rp141.4b market cap, or US$8.35m). Minor Risk Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to Rp530, the stock trades at a trailing P/E ratio of 8.6x. Average trailing P/E is 16x in the Insurance industry in Indonesia. Total returns to shareholders of 9.2% over the past three years. Reported Earnings • Oct 31
Third quarter 2025 earnings released: EPS: Rp0.19 (vs Rp29.94 loss in 3Q 2024) Third quarter 2025 results: EPS: Rp0.19 (up from Rp29.94 loss in 3Q 2024). Revenue: Rp80.7b (up 77% from 3Q 2024). Net income: Rp64.6m (up Rp10.5b from 3Q 2024). Profit margin: 0.1% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Board Change • Oct 24
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. No independent directors (4 non-independent directors). Independent Commissioner Krishna Suparto was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • May 07
PT Asuransi Bintang Tbk announces Annual dividend, payable on May 28, 2025 PT Asuransi Bintang Tbk announced Annual dividend of IDR 3.5000 per share payable on May 28, 2025, ex-date on May 14, 2025 and record date on May 15, 2025. Announcement • Mar 06
PT Asuransi Bintang Tbk, Annual General Meeting, Apr 29, 2025 PT Asuransi Bintang Tbk, Annual General Meeting, Apr 29, 2025. Location: jakarta Indonesia Valuation Update With 7 Day Price Move • Nov 06
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to Rp730, the stock trades at a trailing P/E ratio of 49.1x. Average trailing P/E is 20x in the Insurance industry in Indonesia. Total returns to shareholders of 156% over the past three years. Board Change • Oct 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 7 highly experienced directors. No independent directors (4 non-independent directors). Independent Commissioner Ronald Waas was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Aug 02
Second quarter 2024 earnings released: EPS: Rp10.21 (vs Rp7.92 in 2Q 2023) Second quarter 2024 results: EPS: Rp10.21 (up from Rp7.92 in 2Q 2023). Revenue: Rp57.9b (up 20% from 2Q 2023). Net income: Rp3.41b (up 24% from 2Q 2023). Profit margin: 5.9% (up from 5.7% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 47% per year, which means it is well ahead of earnings. New Risk • Jun 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indonesian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 8.5% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (Rp271.7b market cap, or US$16.6m). Recent Insider Transactions • Jun 21
President Director recently sold Rp1.9m worth of stock On the 19th of June, Hastanto Sri Widodo sold around 2k shares on-market at roughly Rp835 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth Rp4.2m. Hastanto Sri has been a net seller over the last 12 months, reducing personal holdings by Rp6.1m. Recent Insider Transactions • Jun 14
President Director recently sold Rp4.2m worth of stock On the 7th of June, Hastanto Sri Widodo sold around 5k shares on-market at roughly Rp850 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Hastanto Sri's only on-market trade for the last 12 months. Valuation Update With 7 Day Price Move • May 22
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to Rp795, the stock trades at a trailing P/E ratio of 47.7x. Average trailing P/E is 24x in the Insurance industry in Indonesia. Total returns to shareholders of 193% over the past three years. Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to Rp900, the stock trades at a trailing P/E ratio of 54x. Average trailing P/E is 34x in the Insurance industry in Indonesia. Total returns to shareholders of 255% over the past three years. New Risk • Apr 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 5.0% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (Rp324.0b market cap, or US$20.4m). Reported Earnings • Apr 01
Full year 2023 earnings released: EPS: Rp17.00 (vs Rp14.73 in FY 2022) Full year 2023 results: EPS: Rp17.00 (up from Rp14.73 in FY 2022). Revenue: Rp229.2b (down 1.5% from FY 2022). Net income: Rp5.81b (up 13% from FY 2022). Profit margin: 2.5% (up from 2.2% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to Rp850, the stock trades at a trailing P/E ratio of 26x. Average trailing P/E is 20x in the Insurance industry in Indonesia. Total returns to shareholders of 208% over the past three years. New Risk • Nov 05
New major risk - Revenue and earnings growth Earnings have declined by 0.06% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 0.06% per year over the past 5 years. High level of non-cash earnings (28% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (5.1% net profit margin). Market cap is less than US$100m (Rp209.0b market cap, or US$13.4m). New Risk • Aug 05
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 28% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (28% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (9.3% average weekly change). Profit margins are more than 30% lower than last year (2.4% net profit margin). Market cap is less than US$100m (Rp191.6b market cap, or US$12.6m). Reported Earnings • Aug 04
Second quarter 2023 earnings released: EPS: Rp8.47 (vs Rp5.86 in 2Q 2022) Second quarter 2023 results: EPS: Rp8.47 (up from Rp5.86 in 2Q 2022). Revenue: Rp68.4b (up 8.9% from 2Q 2022). Net income: Rp2.76b (up 35% from 2Q 2022). Profit margin: 4.0% (up from 3.3% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Upcoming Dividend • Jul 04
Upcoming dividend of Rp5.00 per share at 1.1% yield Eligible shareholders must have bought the stock before 11 July 2023. Payment date: 26 July 2023. Payout ratio is a comfortable 8.0% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indonesian dividend payers (5.3%). Lower than average of industry peers (2.9%). Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improved over the past week After last week's 34% share price gain to Rp500, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 15x in the Insurance industry in Indonesia. Total returns to shareholders of 80% over the past three years. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Ronald Waas was the last independent director to join the board, commencing their role in 2018. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment deteriorated over the past week After last week's 17% share price decline to Rp466, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 18x in the Insurance industry in Indonesia. Total returns to shareholders of 64% over the past three years. Reported Earnings • Nov 03
Third quarter 2022 earnings released: EPS: Rp3.94 (vs Rp5.41 loss in 3Q 2021) Third quarter 2022 results: EPS: Rp3.94 (up from Rp5.41 loss in 3Q 2021). Revenue: Rp58.4b (up 9.8% from 3Q 2021). Net income: Rp1.48b (up Rp3.36b from 3Q 2021). Profit margin: 2.5% (up from net loss in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improved over the past week After last week's 32% share price gain to Rp550, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 16x in the Insurance industry in Indonesia. Total returns to shareholders of 79% over the past three years. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment deteriorated over the past week After last week's 20% share price decline to Rp446, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 19x in the Insurance industry in Indonesia. Total returns to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • Aug 29
Investor sentiment improved over the past week After last week's 24% share price gain to Rp468, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 20x in the Insurance industry in Indonesia. Total returns to shareholders of 52% over the past three years. Announcement • Jul 09
PT Asuransi Bintang Tbk, Annual General Meeting, Jul 08, 2022 PT Asuransi Bintang Tbk, Annual General Meeting, Jul 08, 2022, at 02:00 Coordinated Universal Time. Location: Head Office PT Asuransi Bintang Tbk Jl RS Fatmawati No.32, Cilandak South Jakarta Indonesia Agenda: To consider The proposal has been submitted in writing to the Boards of Directors by 1 (one) or more shareholders which represent 1/20 (one-twentieth) of the total shares with voting rights; to The proposal shall be delivered and received by the Boards of Directors at least 7 (seven) days prior to the date of The Meeting invitation; to The proposal must be made in good faith, taking into account the interests of the Company, along with the reasons and materials for the proposed agenda of The Meeting and not in conflict with the laws and regulations; to The proposed agenda of the proposed meeting is the agenda of the meeting which requires a decision of the Meeting and according to the Boards of Directors Assessment has fulfilled the requirements in point c of this paragraph; and to ocnsider other matter. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Ronald Waas was the last independent director to join the board, commencing their role in 2018. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improved over the past week After last week's 21% share price gain to Rp334, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 21x in the Insurance industry in Indonesia. Total returns to shareholders of 19% over the past three years. Reported Earnings • Aug 09
Second quarter 2021 earnings released: Rp7.03 loss per share (vs Rp6.88 profit in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: Rp49.3b (down 5.9% from 2Q 2020). Net loss: Rp2.58b (down 208% from profit in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improved over the past week After last week's 29% share price gain to Rp374, the stock trades at a trailing P/E ratio of 35.6x. Average trailing P/E is 26x in the Insurance industry in Indonesia. Total returns to shareholders of 21% over the past three years. Is New 90 Day High Low • Jan 27
New 90-day low: Rp278 The company is down 15% from its price of Rp326 on 26 October 2020. The Indonesian market is up 19% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 17% over the same period. Is New 90 Day High Low • Dec 14
New 90-day low: Rp292 The company is down 14% from its price of Rp340 on 16 September 2020. The Indonesian market is up 16% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 17% over the same period. 
